SCHEMBL321312

SCHEMBL321312

CCOP(=O)(CCCBr)OCC

nearest known ligand 0.54

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
PPARD Q03181 2/20 0.54
TSHR P16473 2/20 0.50
TP53 P04637 1/20 0.39
TDP1 Q9NUW8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1227289 0.93 PPARD (0.52) PPARDTSHRTP53TDP1
SCHEMBL29271053 0.91 PPARD (0.50) PPARDTSHR
SCHEMBL1585191 0.91 PPARD (0.50) PPARDTSHR
Hydrochloric Acid SCHEMBL4879960 0.91 PPARD (0.50) PPARDTSHRTP53TDP1
SCHEMBL2816370 0.91 PPARD (0.50) PPARDTSHR
SCHEMBL2400621 0.91 PPARD (0.50) PPARDTSHR
SCHEMBL864014 0.91 PPARD (0.50) PPARDTSHR
SCHEMBL1527541 0.91 PPARD (0.50) PPARDTSHR
SCHEMBL17577624 0.90 PPARD (0.45) PPARDTSHRTP53TDP1
SCHEMBL331812 0.85 PPARD (0.58) PPARDTSHRTP53TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 338 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118271578-A Polymer with phosphonic acid structure in side chain, synthesis method and application thereof in high-temperature proton exchange membrane fuel cell 中国科学院山西煤炭化学研究所 2024-07-02 CN claimed
CN-117567513-A Self-assembled monolayer hole transport material containing bisphosphonic acid terminal group, preparation method and application 南开大学 2024-02-20 CN claimed
CN-105837627-A Dual functional quaternary ammonium salt ionic liquid and preparation method thereof 宁波大学 2016-08-10 CN claimed
CN-104945435-A Single-tooth double-functionalization imidazole type ionic liquid and preparing method thereof UNIV NINGBO 2015-09-30 CN claimed
CN-104926869-A Double-tooth double-functional imidazole type ionic liquid and preparing method thereof UNIV NINGBO 2015-09-23 CN claimed
EP-4003988-B1 3,6-DIAMINO-PYRIDAZIN-3-YL DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS PRO-APOPTOTIC AGENTS SERVIER LAB (FR) 2026-05-20 EP disclosed
EP-4679984-A1 PHOTOELECTRIC CONVERSION ELEMENT Enecoat Technologies Co., Ltd. (JP) 2026-01-14 EP disclosed
US-12336362-B2 Diamondoid compounds MERCK PATENT GMBH (DE) 2025-06-17 US disclosed
US-20250073236-A1 PYRIMIDINE COMPOUNDS CONTAINING ACIDIC GROUPS APROS THERAPEUTICS INC (US) 2025-03-06 US disclosed
EP-3610868-B1 AMINO- OR AMMONIUM-CONTAINING SULFONIC ACID DERIVATIVES AND THEIR MEDICAL USE GRI BIO INC (US) 2025-02-19 EP disclosed
WO-2025019953-A1 ALTERNATING DUAL-ELECTROLYSER SYSTEMS AND METHODS FOR DIRECT AIR CAPTURE (DAC) AND RELEASE OF CO2 THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) 2025-01-30 WO disclosed
US-12195490-B2 STRAD-binding agents and uses thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-01-14 US disclosed
EP-0309491-A1 ANTIVIRAL AGENTS SRI INTERNATIONAL (US) 1989-04-05 EP disclosed
US-4792616-A Diaryl ethers HOFFMANN-LA ROCHE INC. (US) 1988-12-20 US disclosed
WO-1988005438-A1 ANTIVIRAL AGENTS SRI INTERNATIONAL (US) 1988-07-28 WO disclosed
EP-0161218-A2 Benzo-(pyrano and thiopyrano)pyridines CIBA-GEIGY AG (CH) 1985-11-13 EP disclosed
US-4206156-A ANTIMICROBIAL FUJISAWA PHARMACEUTICAL COMPANY, LIMITED (JP) 1980-06-03 US disclosed
US-4182758-A BACTERICIDES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1980-01-08 US disclosed
US-4026709-A Color photographic recording material CIBA-GEIGY AG (CH) 1977-05-31 US disclosed
US-3984432-A PHOSPHONIC ACID AND PHOSPHORIC ACID DERIVATIVES CIBA-GEIGY AG (CH) 1976-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250073236-A1 PYRIMIDINE COMPOUNDS CONTAINING ACIDIC GROUPS MAVS, TLR7, STING1 PPARD 371/4885TSHR 3962/4885TP53 58/4885
US-12336362-B2 Diamondoid compounds CCND2, ZYX, CCNB2 PPARD 3594/4885TSHR 3839/4885TP53 2929/4885
US-12195490-B2 STRAD-binding agents and uses thereof STRAP, STRA6, PLAUR PPARD 2083/4885TSHR 1833/4885TP53 2499/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.